PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930065
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930065
Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of pen needles Market
The global pen needles market was valued at USD 2.41 billion in 2025. As per the report timeline, the market is projected to grow to USD 2.56 billion in 2026 and further reach USD 4.58 billion by 2034, registering a CAGR of 7.50% during the 2026-2034 forecast period. North America dominated the global market with a 39.60% share in 2025, supported by high adoption of injectable drug delivery devices and a strong presence of established medical device manufacturers.
Pen needles are disposable medical devices used with injection pens to administer drugs such as insulin, GLP-1 receptor agonists, growth hormone, and other injectable therapies. These needles are replaced after single or limited use, which significantly increases recurring demand. The rising prevalence of chronic diseases such as diabetes, osteoporosis, obesity, and hormone deficiencies is a key contributor to market expansion.
MARKET DRIVERS
The increasing global burden of chronic diseases has been a major driver of pen needle demand. In 2025, diabetes accounted for the largest share of pen needle usage, driven by long-term insulin dependence among patients. The expanding adoption of injectable GLP-1 therapies for diabetes and obesity has further increased reliance on pen-based drug delivery systems.
Market players are actively expanding their product portfolios through acquisitions, partnerships, and new launches. For instance, MTD Medical Technology and Devices S.p.A. strengthened its presence in the pen needle segment by acquiring pen needle and blood glucose monitoring businesses, improving product availability across multiple regions. Additionally, the expansion of over-the-counter (OTC) availability of pen needles in developed markets has supported higher accessibility and volume growth.
MARKET RESTRAINTS
Despite strong demand, the pen needles market faces certain limitations. Risks associated with needlestick injuries, injection-site reactions, and infection transmission remain key concerns for patients and healthcare professionals. Improper injection techniques and repeated injections in the same area can result in complications such as lipohypertrophy and skin infections. Furthermore, the availability of alternative treatment options, including oral medications for diabetes and osteoporosis, continues to restrict market penetration in specific patient groups.
SEGMENTATION ANALYSIS
By Product Type:
Standard pen needles held a dominant position, accounting for 67.97% of the global market share in 2026. Their widespread use is driven by cost-effectiveness and high adoption among diabetes patients. Safety pen needles are expected to grow at a faster pace due to increasing awareness regarding needlestick injury prevention.
By Drug Type:
The insulin segment dominated the market with a 75.39% share in 2026, reflecting the high dependence on insulin for diabetes management. GLP-1 and other injectable drug categories are expected to experience steady growth through 2034.
By Disease Indication:
Diabetes remained the leading disease indication, contributing 83.59% of global demand in 2026. This dominance is supported by rising disease prevalence and continuous innovation in insulin delivery systems by manufacturers.
By Needle Size:
The 4 mm needle segment accounted for 49.61% of the market in 2026, driven by reduced pain perception and lower risk of intramuscular injection. Demand for 6 mm needles is increasing due to their balance between safety and delivery efficiency.
By Distribution Channel:
Retail pharmacies dominated the market in 2025 due to patient preference for easy access and in-store availability. Online pharmacies are projected to grow rapidly through 2034, supported by home delivery convenience and digital healthcare adoption.
REGIONAL INSIGHTS
North America remained the leading region, driven by advanced healthcare infrastructure and strong manufacturer presence. The regional market reached USD 0.96 billion by 2026, supported by companies such as Embecta Corp. and Cardinal Health.
Europe is expected to witness steady growth through 2034, supported by a high prevalence of diabetes and increased preference for self-administered insulin therapies. Asia Pacific is projected to grow at the fastest rate due to expanding patient populations, rising awareness of injectable therapies, and increased pharmaceutical investments in countries such as China, India, and Japan.
KEY INDUSTRY PLAYERS
The competitive landscape includes Novo Nordisk A/S, Terumo Corporation, BD, Owen Mumford, and B. Braun SE. These companies continue to focus on innovation, safety-enhanced designs, and global distribution expansion.
REPORT COVERAGE
The pen needles market report provides detailed insights into market size trends for 2025, 2026, and 2034, along with segmentation analysis, regional outlook, competitive landscape, and the impact of COVID-19. The report also covers key industry developments, including mergers, acquisitions, partnerships, and new product launches influencing market dynamics during the forecast period.
CONCLUSION
The global pen needles market demonstrates consistent expansion across the report timeline, supported by strong demand from chronic disease management and the growing preference for self-administered injectable therapies. With the market valued at USD 2.41 billion in 2025, rising to USD 2.56 billion in 2026, and projected to reach USD 4.58 billion by 2034, growth remains firmly anchored in diabetes care, which accounted for 83.59% of total demand in 2026. The dominance of standard pen needles (67.97% share in 2026) and shorter needle sizes such as 4 mm (49.61% share in 2026) reflects patient preference for cost-effective, low-pain solutions. Regionally, North America's leadership (39.60% share in 2025) highlights the impact of advanced healthcare infrastructure and high adoption of injection pens. Continued innovation, portfolio expansion, and broader accessibility through retail and online pharmacies are expected to sustain market momentum through 2034.
Segmentation By Product Type
- Standard Pen Needles
- Safety Pen Needles
By Drug Type
- Insulin
- GLP-1
- Growth Hormone
- Others
By Disease Indication
- Diabetes
- Obesity
- Hormone Deficiency
- Others
By Needle Size
- 4 mm
- 5 mm
- 6 mm
- 8 mm
- 12 mm
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region
- North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
- U.S.
- Canada
- Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
- Japan
- China
- Australia
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
- South Africa
- GCC
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
- 4.2. Prevalence of Obesity - by Key Countries/Regions, 2025
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.4. Impact of COVID-19 on the Market
5. Global Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Standard Pen Needles
- 5.1.2. Safety Pen Needles
- 5.2. Market Analysis, Insights and Forecast - By Drug Type
- 5.2.1. Insulin
- 5.2.2. GLP-1
- 5.2.3. Growth Hormone
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Disease Indication
- 5.3.1. Diabetes
- 5.3.2. Obesity
- 5.3.3. Hormone Deficiency
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Needle Size
- 5.4.1. 4 mm
- 5.4.2. 5 mm
- 5.4.3. 6 mm
- 5.4.4. 8 mm
- 5.4.5. 12 mm
- 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.5.1. Hospital Pharmacy
- 5.5.2. Retail Pharmacy
- 5.5.3. Online Pharmacy
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Standard Pen Needles
- 6.1.2. Safety Pen Needles
- 6.2. Market Analysis, Insights and Forecast - By Drug Type
- 6.2.1. Insulin
- 6.2.2. GLP-1
- 6.2.3. Growth Hormone
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Disease Indication
- 6.3.1. Diabetes
- 6.3.2. Obesity
- 6.3.3. Hormone Deficiency
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Needle Size
- 6.4.1. 4 mm
- 6.4.2. 5 mm
- 6.4.3. 6 mm
- 6.4.4. 8 mm
- 6.4.5. 12 mm
- 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.5.1. Hospital Pharmacy
- 6.5.2. Retail Pharmacy
- 6.5.3. Online Pharmacy
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Standard Pen Needles
- 7.1.2. Safety Pen Needles
- 7.2. Market Analysis, Insights and Forecast - By Drug Type
- 7.2.1. Insulin
- 7.2.2. GLP-1
- 7.2.3. Growth Hormone
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Disease Indication
- 7.3.1. Diabetes
- 7.3.2. Obesity
- 7.3.3. Hormone Deficiency
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Needle Size
- 7.4.1. 4 mm
- 7.4.2. 5 mm
- 7.4.3. 6 mm
- 7.4.4. 8 mm
- 7.4.5. 12 mm
- 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.5.1. Hospital Pharmacy
- 7.5.2. Retail Pharmacy
- 7.5.3. Online Pharmacy
- 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Spain
- 7.6.5. Italy
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
8. Asia Pacific Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Standard Pen Needles
- 8.1.2. Safety Pen Needles
- 8.2. Market Analysis, Insights and Forecast - By Drug Type
- 8.2.1. Insulin
- 8.2.2. GLP-1
- 8.2.3. Growth Hormone
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Disease Indication
- 8.3.1. Diabetes
- 8.3.2. Obesity
- 8.3.3. Hormone Deficiency
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Needle Size
- 8.4.1. 4 mm
- 8.4.2. 5 mm
- 8.4.3. 6 mm
- 8.4.4. 8 mm
- 8.4.5. 12 mm
- 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.5.1. Hospital Pharmacy
- 8.5.2. Retail Pharmacy
- 8.5.3. Online Pharmacy
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. Australia
- 8.6.4. India
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Standard Pen Needles
- 9.1.2. Safety Pen Needles
- 9.2. Market Analysis, Insights and Forecast - By Drug Type
- 9.2.1. Insulin
- 9.2.2. GLP-1
- 9.2.3. Growth Hormone
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Disease Indication
- 9.3.1. Diabetes
- 9.3.2. Obesity
- 9.3.3. Hormone Deficiency
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Needle Size
- 9.4.1. 4 mm
- 9.4.2. 5 mm
- 9.4.3. 6 mm
- 9.4.4. 8 mm
- 9.4.5. 12 mm
- 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.5.1. Hospital Pharmacy
- 9.5.2. Retail Pharmacy
- 9.5.3. Online Pharmacy
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
10. Middle East & Africa Pen Needles Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. Standard Pen Needles
- 10.1.2. Safety Pen Needles
- 10.2. Market Analysis, Insights and Forecast - By Drug Type
- 10.2.1. Insulin
- 10.2.2. GLP-1
- 10.2.3. Growth Hormone
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Disease Indication
- 10.3.1. Diabetes
- 10.3.2. Obesity
- 10.3.3. Hormone Deficiency
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Needle Size
- 10.4.1. 4 mm
- 10.4.2. 5 mm
- 10.4.3. 6 mm
- 10.4.4. 8 mm
- 10.4.5. 12 mm
- 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.5.1. Hospital Pharmacy
- 10.5.2. Retail Pharmacy
- 10.5.3. Online Pharmacy
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. South Africa
- 10.6.2. GCC
- 10.6.3. Rest of Latin America
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Novo Nordisk A/S
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Embecta Corp.
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. B. Braun SE
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Owen Mumford
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. BD
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Cardinal Health
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. SOL-Millennium
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Terumo Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. MTD Medical Technology and Devices S.p.A.
- 11.2.9.1. Overview
- 11.2.9.2. Products & services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. UltiMed, Inc.
- 11.2.10.1. Overview
- 11.2.10.2. Products & services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. Allison Medical, Inc.
- 11.2.11.1. Overview
- 11.2.11.2. Products & services
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
- 11.2.1. Novo Nordisk A/S
List of Tables
- Table 1: Global Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 2: Global Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 3: Global Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 4: Global Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 5: Global Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 6: Global Pen Needles Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 7: North America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 8: North America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 9: North America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 10: North America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 11: North America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 12: North America Pen Needles Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13: Europe Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 14: Europe Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 15: Europe Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 16: Europe Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 17: Europe Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 18: Europe Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 19: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 20: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 21: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 22: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 23: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 24: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 25: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 26: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 27: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 28: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 29: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 30: Latin America Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 32: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
- Table 33: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
- Table 34: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
- Table 35: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 36: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Pen Needles Market Value Share (%), by Product Type, 2025 & 2034
- Figure 3: Global Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
- Figure 4: Global Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
- Figure 5: Global Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
- Figure 6: Global Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
- Figure 7: Global Pen Needles Market Value (USD billion), by Region, 2025 & 2034
- Figure 8: North America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 9: North America Pen Needles Market Value Share (%), by Product Type, 2025
- Figure 10: North America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
- Figure 11: North America Pen Needles Market Value Share (%), by Drug Type, 2025
- Figure 12: North America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
- Figure 13: North America Pen Needles Market Value Share (%), by Needle Size, 2025
- Figure 14: North America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
- Figure 15: North America Pen Needles Market Value Share (%), by Disease Indication, 2025
- Figure 16: North America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 17: North America Pen Needles Market Value Share (%), by Distribution Channel, 2025
- Figure 18: North America Pen Needles Market Value (USD billion), By Country, 2025 & 2034
- Figure 19: North America Pen Needles Market Value Share (%), By Country, 2025
- Figure 20: Europe Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 21: Europe Pen Needles Market Value Share (%), by Product Type, 2025
- Figure 22: Europe Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
- Figure 23: Europe Pen Needles Market Value Share (%), by Drug Type, 2025
- Figure 24: Europe Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
- Figure 25: Europe Pen Needles Market Value Share (%), by Needle Size, 2025
- Figure 26: Europe Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
- Figure 27: Europe Pen Needles Market Value Share (%), by Disease Indication, 2025
- Figure 28: Europe Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 29: Europe Pen Needles Market Value Share (%), by Distribution Channel, 2025
- Figure 30: Europe Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 31: Europe Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
- Figure 32: Asia Pacific Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 33: Asia Pacific Pen Needles Market Value Share (%), by Product Type, 2025
- Figure 34: Asia Pacific Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
- Figure 35: Asia Pacific Pen Needles Market Value Share (%), by Drug Type, 2025
- Figure 36: Asia Pacific Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
- Figure 37: Asia Pacific Pen Needles Market Value Share (%), by Needle Size, 2025
- Figure 38: Asia Pacific Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
- Figure 39: Asia Pacific Pen Needles Market Value Share (%), by Disease Indication, 2025
- Figure 40: Asia Pacific Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 41: Asia Pacific Pen Needles Market Value Share (%), by Distribution Channel, 2025
- Figure 42: Asia Pacific Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 43: Asia Pacific Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
- Figure 44: Latin America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 45: Latin America Pen Needles Market Value Share (%), by Product Type, 2025
- Figure 46: Latin America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
- Figure 47: Latin America Pen Needles Market Value Share (%), by Drug Type, 2025
- Figure 48: Latin America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
- Figure 49: Latin America Pen Needles Market Value Share (%), by Needle Size, 2025
- Figure 50: Latin America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
- Figure 51: Latin America Pen Needles Market Value Share (%), by Disease Indication, 2025
- Figure 52: Latin America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 53: Latin America Pen Needles Market Value Share (%), by Distribution Channel, 2025
- Figure 54: Latin America Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 55: Latin America Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
- Figure 56: Middle East & Africa Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 57: Middle East & Africa Pen Needles Market Value Share (%), by Product Type, 2025
- Figure 58: Middle East & Africa Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
- Figure 59: Middle East & Africa Pen Needles Market Value Share (%), by Drug Type, 2025
- Figure 60: Middle East & Africa Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
- Figure 61: Middle East & Africa Pen Needles Market Value Share (%), by Needle Size, 2025
- Figure 62: Middle East & Africa Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
- Figure 63: Middle East & Africa Pen Needles Market Value Share (%), by Disease Indication, 2025
- Figure 64: Middle East & Africa Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 65: Middle East & Africa Pen Needles Market Value Share (%), by Distribution Channel, 2025
- Figure 66: Middle East & Africa Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 67: Middle East & Africa Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
- Figure 68: Global Pen Needles Market Share (%), By Company, 2025
